RISK OF NEUROLOGICAL ADVERSE EVENTS DURING TUMOUR NECROSIS FACTOR INHIBITOR TREATMENT FOR ARTHRITIS: A POPULATION-BASED COHORT STUDY FROM DANBIO AND ARTIS

被引：0
|
作者：
Kopp, Tine Iskov [1 ]
Arkema, Elizabeth [2 ]
Cordtz, Rene [3 ]
Delcoigne, Benedicte [2 ]
Askling, Johan [2 ]
Dreyer, Lene [4 ,5 ]
机构：
[1] Rigshosp, Copenhagen Univ Hosp, Dept Neurol, Danish Multiple Sclerosis Registry, Copenhagen, Denmark
[2] Karolinska Inst, Dept Med Solna, Stockholm, Sweden
[3] Parker Inst, Ctr Rheumatol & Spine Dis, Gentofte, Denmark
[4] Aalborg Univ Hosp, Aalborg, Denmark
[5] Aalborg Univ, DANBIO, Dept Rheumatol, Aalborg, Denmark
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.1747
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0261
引用
收藏
页码：211 / 211
页数：1
相关论文
共 50 条
  • [1] Risk of neurological adverse events during tumour necrosis factor inhibitor treatment for arthritis: A population-based cohort study from DANBIO and the Danish National Patient Registry
    Kopp, Tine I.
    Jacobsen, Rikke K.
    Magyari, Melinda
    Ibfelt, Else H.
    Locht, Henning
    Sellebjerg, Finn T.
    Vendelbo, Dorte
    Cordtz, Rene
    Dreyer, Lene
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 145 - 145
  • [2] Risk of Neurological Adverse Events during Tumour Necrosis Factor Inhibitor Treatment for Arthritis: A Population-Based Cohort Study from Danbio and the Danish National Patient Registry
    Dreyer, Lene
    Kopp, Tine Iskov
    Jacobsen, Rikke Kart
    Magyari, Melinda
    Ibfelt, Else Helene
    Locht, Henning
    Sellebjerg, Finn Thorup
    Jensen, Dorte Vendelbo
    Cordtz, Rene
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [3] Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry
    Dreyer, L.
    Magyari, M.
    Laursen, B.
    Cordtz, R.
    Sellebjerg, F.
    Locht, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (04) : 785 - 786
  • [4] Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry (DMSR)
    Dreyer, L.
    Magyari, M.
    Laursen, B.
    Cordtz, R.
    Sellebjerg, F.
    Locht, H.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 : 27 - 28
  • [5] PRESCRIPTION PATTERNS OF TUMOUR NECROSIS FACTOR INHIBITOR AND USTEKINUMAB IN PSORIATIC ARTHRITIS: A NORDIC POPULATION-BASED COHORT STUDY
    Jorgensen, T. S.
    Dreyer, L.
    Gudbjornsson, B.
    Hetland, M. L.
    Glintborg, B.
    Askling, J.
    Chatzidionysiou, K.
    Di Giuseppe, D.
    Jacobsson, L.
    Wallman, J. K.
    Kristianslund, E. K.
    Olsen, I. C.
    Fagerli, K.
    Lie, E.
    Nordstrom, D.
    Aaltonen, K.
    Joensuu, J.
    Love, T. J.
    Geirsson, A. J.
    Kristensen, L. E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 686 - 686
  • [6] MULTIPLE SCLEROSIS DURING TUMOR NECROSIS FACTOR INHIBITOR TREATMENT FOR ARTHRITIS - A POPULATION BASED STUDY FROM DANBIO AND THE DANISH MULTIPLE SCLEROSIS REGISTRY
    Dreyer, L.
    Magyari, M.
    Laursen, B.
    Cordtz, R.
    Sellebjerg, F.
    Locht, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 708 - 708
  • [7] Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden
    Kopp, Tine Iskov
    Delcoigne, Benedicte
    Arkema, Elizabeth V.
    Jacobsen, Rikke Kart
    Magyari, Melinda
    Ibfelt, Else Helene
    Locht, Henning
    Sellebjerg, Finn
    Cordtz, Rene Lindholm
    Jensen, Dorte V.
    Askling, Johan
    Dreyer, Lene
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (05) : 566 - 572
  • [8] THE IMPACT OF COMORBIDITIES ON EFFECT AND DISCONTINUATION OF TUMOUR NECROSIS FACTOR INHIBITOR THERAPY IN PSORIATIC ARTHRITIS: A POPULATION-BASED COHORT STUDY
    Ballegaard, C.
    Hojgaard, P.
    Dreyer, L.
    Cordtz, R.
    Jorgensen, T. S.
    Skougaard, M.
    Tarp, S.
    Kristensen, L. E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 96 - 96
  • [9] FATIGUE REMAINS A DOMINATNG SYMPTOM DESPITE TUMOUR NECROSIS FACTOR INHIBITOR THERAPY IN PSORIATIC ARTHRITIS: A POPULATION-BASED COHORT STUDY
    Jorgensen, T. S.
    Skougaard, M.
    Ballegaard, C.
    Mease, P.
    Strand, V.
    Dreyer, L.
    Kristensen, L. E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 384 - 385
  • [10] Impact of Comorbidities on Tumor Necrosis Factor Inhibitor Therapy in Psoriatic Arthritis: A Population-Based Cohort Study
    Ballegaard, Christine
    Hojgaard, Pil
    Dreyer, Lene
    Cordtz, Rene
    Jorgensen, Tanja Schjodt
    Skougaard, Marie
    Tarp, Simon
    Kristensen, Lars Erik
    [J]. ARTHRITIS CARE & RESEARCH, 2018, 70 (04) : 592 - 599
12345